(17314293), C. R., (21632380), A. O., (21632383), C. M., (15331351), R. B., (21468025), D. J., (16494599), C. S., . . . (15055771), P. K. P. (2025). Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib.
Citace podle Chicago (17th ed.)(17314293), Christian Rolfo, Aurora O’Brate (21632380), Christoph Menzel (21632383), Rolf Bruns (15331351), Dilafruz Juraeva (21468025), Christopher Stroh (16494599), Andreas Johne (15331354), a Paul K. Paik (15055771). Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib. 2025.
Citace podle MLA (9th ed.)(17314293), Christian Rolfo, et al. Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib. 2025.